Literature DB >> 23296070

Revising common beliefs in the management of stable CAD.

Roberto Ferrari1.   

Abstract

New findings published in 2012 have challenged common beliefs about stable coronary artery disease. Studies have shown that β-blockers and n-3-polyunsaturated fatty acids have no impact on prognosis, that percutaneous coronary intervention is not always the best option, and that women do not have worse cardiovascular outcomes than men.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23296070     DOI： 10.1038/nrcardio.2012.184

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

1.  Is technological change in medicine worth it?

Authors:  D M Cutler; M McClellan
Journal:  Health Aff (Millwood)       Date:  2001 Sep-Oct       Impact factor: 6.301

2.  n-3 fatty acids and cardiovascular events after myocardial infarction.

Authors:  Daan Kromhout; Erik J Giltay; Johanna M Geleijnse
Journal:  N Engl J Med       Date:  2010-08-28       Impact factor: 91.245

3.  n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

Authors:  Jackie Bosch; Hertzel C Gerstein; Gilles R Dagenais; Rafael Díaz; Leanne Dyal; Hyejung Jung; Aldo P Maggiono; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf
Journal:  N Engl J Med       Date:  2012-06-11       Impact factor: 91.245

4.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

5.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

Authors: 
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

6.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

7.  Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.

Authors:  Grace A Lin; R Adams Dudley; F L Lucas; David J Malenka; Eric Vittinghoff; Rita F Redberg
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

8.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

Authors:  Bernard De Bruyne; Nico H J Pijls; Bindu Kalesan; Emanuele Barbato; Pim A L Tonino; Zsolt Piroth; Nikola Jagic; Sven Möbius-Winkler; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith G Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Peter Jüni; William F Fearon
Journal:  N Engl J Med       Date:  2012-08-27       Impact factor: 91.245

9.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Roberto Marchioli; Simona Barlera; Maria Grazia Franzosi; Roberto Latini; Donata Lucci; Gian Luigi Nicolosi; Maurizio Porcu; Gianni Tognoni
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

10.  Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry.

Authors:  Ph Gabriel Steg; Nicola Greenlaw; Jean-Claude Tardif; Michal Tendera; Ian Ford; Stefan Kääb; Hélène Abergel; Kim M Fox; Roberto Ferrari
Journal:  Eur Heart J       Date:  2012-08-26       Impact factor: 29.983
  10 in total
  4 in total

Review 1.  Expert consensus document: A 'diamond' approach to personalized treatment of angina.

Authors:  Roberto Ferrari; Paolo G Camici; Filippo Crea; Nicolas Danchin; Kim Fox; Aldo P Maggioni; Athanasios J Manolis; Mario Marzilli; Giuseppe M C Rosano; José L Lopez-Sendon
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

Review 2.  Heart rate reduction in coronary artery disease and heart failure.

Authors:  Roberto Ferrari; Kim Fox
Journal:  Nat Rev Cardiol       Date:  2016-05-26       Impact factor: 32.419

3.  Effects of administration of omega-3 fatty acids with or without vitamin E supplementation on adiponectin gene expression in PBMCs and serum adiponectin and adipocyte fatty acid-binding protein levels in male patients with CAD.

Authors:  Atena Ramezani; Fariba Koohdani; Abolghasem Djazayeri; Ebrahim Nematipour; Seyed Ali Keshavarz; Ali Akbar Saboor Yaraghi; Mohammad Reza Eshraghian; Abbas Yousefinejad; Hassan Javanbakht; Mahnaz Zarei; Sanaz Gholamhosseini; Mahmoud Djalali
Journal:  Anatol J Cardiol       Date:  2015-04-02       Impact factor: 1.596

4.  Treating angina.

Authors:  Roberto Ferrari; S Censi; A Squeri
Journal:  Eur Heart J Suppl       Date:  2019-11-12       Impact factor: 1.803
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.